DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Escudier B, Chevreau C, Lasset C, Douillard JY, Ravaud A, Fabbro M, Caty A, Rossi JF, Viens P, Bergerat JP, Savary J, Négrier S.
Cytokines in metastatic renal cell carcinoma: is it useful to switch to interleukin-2 or interferon after failure of a first treatment? Groupe Français d’Immunothérape.
J Clin Oncol 1999; 17: 2039-2043
We do not assume any responsibility for the contents of the web pages of other providers.